268 related articles for article (PubMed ID: 22133902)
1. Bicyclic benzofuran and indole-based salicylic acids as protein tyrosine phosphatase inhibitors.
He Y; Zeng LF; Yu ZH; He R; Liu S; Zhang ZY
Bioorg Med Chem; 2012 Mar; 20(6):1940-6. PubMed ID: 22133902
[TBL] [Abstract][Full Text] [Related]
2. Drugging the Undruggable: Therapeutic Potential of Targeting Protein Tyrosine Phosphatases.
Zhang ZY
Acc Chem Res; 2017 Jan; 50(1):122-129. PubMed ID: 27977138
[TBL] [Abstract][Full Text] [Related]
3. Discovery and evaluation of novel inhibitors of mycobacterium protein tyrosine phosphatase B from the 6-Hydroxy-benzofuran-5-carboxylic acid scaffold.
He Y; Xu J; Yu ZH; Gunawan AM; Wu L; Wang L; Zhang ZY
J Med Chem; 2013 Feb; 56(3):832-42. PubMed ID: 23305444
[TBL] [Abstract][Full Text] [Related]
4. Probing the molecular basis for potent and selective protein-tyrosine phosphatase 1B inhibition.
Guo XL; Shen K; Wang F; Lawrence DS; Zhang ZY
J Biol Chem; 2002 Oct; 277(43):41014-22. PubMed ID: 12193602
[TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development.
Zhang ZY
Annu Rev Pharmacol Toxicol; 2002; 42():209-34. PubMed ID: 11807171
[TBL] [Abstract][Full Text] [Related]
6. Protein tyrosine phosphatases as potential therapeutic targets.
He RJ; Yu ZH; Zhang RY; Zhang ZY
Acta Pharmacol Sin; 2014 Oct; 35(10):1227-46. PubMed ID: 25220640
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyindole carboxylic acid-based inhibitors for receptor-type protein tyrosine protein phosphatase beta.
Zeng LF; Zhang RY; Bai Y; Wu L; Gunawan AM; Zhang ZY
Antioxid Redox Signal; 2014 May; 20(14):2130-40. PubMed ID: 24180557
[TBL] [Abstract][Full Text] [Related]
8. Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations.
Bishop AC; Zhang XY; Lone AM
Methods; 2007 Jul; 42(3):278-88. PubMed ID: 17532515
[TBL] [Abstract][Full Text] [Related]
9. Druggable targets of protein tyrosine phosphatase Family, viz. PTP1B, SHP2, Cdc25, and LMW-PTP: Current scenario on medicinal Attributes, and SAR insights.
Bhavana ; Kohal R; Kumari P; Das Gupta G; Kumar Verma S
Bioorg Chem; 2024 Mar; 144():107121. PubMed ID: 38237392
[TBL] [Abstract][Full Text] [Related]
10. Novel benzofuran and benzothiophene biphenyls as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties.
Malamas MS; Sredy J; Moxham C; Katz A; Xu W; McDevitt R; Adebayo FO; Sawicki DR; Seestaller L; Sullivan D; Taylor JR
J Med Chem; 2000 Apr; 43(7):1293-310. PubMed ID: 10753467
[TBL] [Abstract][Full Text] [Related]
11. Functional studies of protein tyrosine phosphatases with chemical approaches.
Zhang ZY
Biochim Biophys Acta; 2005 Dec; 1754(1-2):100-7. PubMed ID: 16226063
[TBL] [Abstract][Full Text] [Related]
12. Recent development of small molecular specific inhibitor of protein tyrosine phosphatase 1B.
Lee S; Wang Q
Med Res Rev; 2007 Jul; 27(4):553-73. PubMed ID: 17039461
[TBL] [Abstract][Full Text] [Related]
13. Small molecule tools for functional interrogation of protein tyrosine phosphatases.
He R; Zeng LF; He Y; Zhang S; Zhang ZY
FEBS J; 2013 Jan; 280(2):731-50. PubMed ID: 22816879
[TBL] [Abstract][Full Text] [Related]
14. Functional interrogation and therapeutic targeting of protein tyrosine phosphatases.
Krabill AD; Zhang ZY
Biochem Soc Trans; 2021 Aug; 49(4):1723-1734. PubMed ID: 34431504
[TBL] [Abstract][Full Text] [Related]
15. A New Paradigm for KIM-PTP Drug Discovery: Identification of Allosteric Sites with Potential for Selective Inhibition Using Virtual Screening and LEI Analysis.
Adams J; Thornton BP; Tabernero L
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830087
[TBL] [Abstract][Full Text] [Related]
16. Druggability analysis and classification of protein tyrosine phosphatase active sites.
Ghattas MA; Raslan N; Sadeq A; Al Sorkhy M; Atatreh N
Drug Des Devel Ther; 2016; 10():3197-3209. PubMed ID: 27757011
[TBL] [Abstract][Full Text] [Related]
17. Allele-specific inhibitors of protein tyrosine phosphatases.
Hoffman HE; Blair ER; Johndrow JE; Bishop AC
J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
[TBL] [Abstract][Full Text] [Related]
18. Drug discovery and protein tyrosine phosphatases.
Blaskovich MA
Curr Med Chem; 2009; 16(17):2095-176. PubMed ID: 19519384
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a novel shp2 protein tyrosine phosphatase inhibitor.
Chen L; Sung SS; Yip ML; Lawrence HR; Ren Y; Guida WC; Sebti SM; Lawrence NJ; Wu J
Mol Pharmacol; 2006 Aug; 70(2):562-70. PubMed ID: 16717135
[TBL] [Abstract][Full Text] [Related]
20. MAPK-specific tyrosine phosphatases: new targets for drug discovery?
Barr AJ; Knapp S
Trends Pharmacol Sci; 2006 Oct; 27(10):525-30. PubMed ID: 16919785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
